Structure | Chemical Name | CAS | MF |
|
2-CHLORO-7-FLUOROBENZOTHIAZOLE
|
154327-28-3
|
C7H3ClFNS
|
|
7-Fluoro-3H-benzothiazole-2-thione
|
154327-29-4
|
C7H4FNS2
|
|
Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate
|
154330-67-3
|
C14H13F2NO3S
|
|
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate
|
154330-68-4
|
C16H15F2NO4S
|
|
t-butyloxycarbonyl-leucyl-dipropylglycyl-valine methyl ester
|
154331-04-1
|
C25H47N3O6
|
|
Silver sodium zirconium phosphate
|
154339-84-1
|
|
|
2,7-Thianthrenedicarboxylic Acid
|
154341-96-5
|
C14H8O4S2
|
|
2,8-Thianthrenedicarboxylic Acid
|
154341-97-6
|
C14H8O4S2
|
|
L-Proline, 1-ethyl-4-hydroxy-, methyl ester, trans- (9CI)
|
154342-67-3
|
C8H15NO3
|
|
3-chloro-N-(2,5-dimethoxyphenyl)propanamide
|
154343-50-7
|
C11H14ClNO3
|
|
2-CHLORO-5,8-DIMETHOXY-QUINOLINE-3-CARBALDEHYDE
|
154343-51-8
|
C12H10ClNO3
|
|
2′,2′′,4′′′-Trifluor-4-propyl-1,1′:4′,1′′-terphenyl
|
154346-21-1
|
C21H17F3
|
|
Oxiranecarboxylic acid, 2-acetyl-, ethyl ester (9CI)
|
154346-53-9
|
C7H10O4
|
|
5-{[(4-methylphenyl)methyl]sulfanyl}-1,3,4-thiadiazol-2-amine
|
154347-43-0
|
C10H11N3S2
|
|
tert-butyl 1-oxo-2-oxa-8-azaspiro[4.5]decane-8-carboxylate
|
154348-08-0
|
C13H21NO4
|
|
Ethanethioamide, N-methyl-N-(phenylmethyl)-
|
154349-19-6
|
C10H13NS
|
|
CYCLOPROPANESULPHONAMIDE
|
154350-28-4
|
C3H7NO2S
|
|
Cyclopropanesulfonamide
|
154350-29-5
|
C3H7NO2S
|
|
4-(3-Formyl-indol-1-yl)-benzoic acid tert-butyl ester
|
154350-90-0
|
C20H19NO3
|
|
2-(4-Hydroxymethylphenyl)isonicotinic acid
|
154352-41-7
|
C14H13NO3
|
|
Benzenepropanamide, alpha-fluoro-N,N-dimethyl-beta-oxo- (9CI)
|
154353-55-6
|
C11H12FNO2
|
|
8-methoxycarbonyloctyl-3-O-glucopyranosyl-mannopyranoside
|
154354-46-8
|
C22H40O13
|
|
ATRELEUTON
|
154355-75-6
|
C16H15FN2O2S
|
|
1-[(2R)-4-[5-[(4-fluorophenyl)methyl]thiophen-2-yl]but-3-yn-2-yl]-1-hydroxy-urea
|
154355-76-7
|
C16H15FN2O2S
|
|
Thiophene, 2-[(4-fluorophenyl)Methyl]-5-iodo-
|
154355-88-1
|
C11H8FIS
|
|
22-dehydro-1,25-dihydroxy-24-dihomovitamin D3
|
154356-84-0
|
C29H46O3
|
|
(4-Chlorophenyl)[4-(1-Methylethoxy)phenyl]Methanone (Fenofibrate IMpurity)
|
154356-96-4
|
C16H15ClO2
|
|
(S)-(-)-Nadifloxacin
|
154357-42-3
|
C19H21FN2O4
|
|
3-trifluoromethyl-1H-5-chloropyrazole-4-Carbaldehyde
|
154357-44-5
|
C5H2ClF3N2O
|
|
TRIMETHYLPHOSPHONIUM TETRAFLUOROBORATE
|
154358-50-6
|
C3H10BF4P
|
|
Arcitumomab
|
154361-48-5
|
|
|
Capecitabine
|
154361-50-9
|
C15H22FN3O6
|
|
Desmethoxyacetyliopromid
|
154361-51-0
|
C15H20I3N3O6
|
|
Iopromide EP Impurity C
|
154361-52-1
|
C17H22I3N3O8
|
|
(Gly21)-Amyloid β-Protein (1-40)
|
154362-03-5
|
C19H12FN5O3S2
|
|
ETHYL 6-ETHOXY-2-HYDROXYBENZOATE 95
|
154364-61-1
|
C11H14O4
|
|
ETHYL 2-METHYL-3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE
|
154365-33-0
|
C12H13NO4
|
|
ETHYL 2-METHYL-7-NITRO-3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE
|
154365-36-3
|
C12H12N2O6
|
|
Ethyl 3,4-dihydro-2-methyl-6-nitro-3-oxo-2H-1,4-benzoxazine-2-carboxylate
|
154365-37-4
|
C12H12N2O6
|
|
ETHYL 2-METHYL-3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZINE-2-CARBOXYLATE
|
154365-38-5
|
C11H12N2O4
|
|
3,4-Dihydro-2-methyl-3-oxo-2H-1,4-benzoxazine-2-carboxylic acid
|
154365-40-9
|
C10H9NO4
|
|
3,4-Dihydro-2-methyl-7-nitro-3-oxo-2H-1,4-benzoxazine-2-carboxylic acid
|
154365-43-2
|
C10H8N2O6
|
|
3,4-Dihydro-2-methyl-6-nitro-3-oxo-2H-1,4-benzoxazine-2-carboxylic acid
|
154365-44-3
|
C10H8N2O6
|
|
2-METHYL-3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZINE-2-CARBOXYLIC ACID
|
154365-45-4
|
C9H8N2O4
|
|
2-Cyclobutene-1-carbonitrile,2-ethenyl-1,3-diethoxy-4-oxo-(9CI)
|
154365-61-4
|
C11H13NO3
|
|
1H-Pyrazole-1-carboxamide,5-amino-N-ethyl-(9CI)
|
154366-36-6
|
C6H10N4O
|
|
1H-Pyrazole-1-carboxamide,3-amino-N-ethyl-(9CI)
|
154366-40-2
|
C6H10N4O
|
|
1H-Pyrazole-1-carboxamide, 3-(acetylamino)-N-methyl-
|
154366-45-7
|
C7H10N4O2
|
|
3H-Pyrrolizin-3-one,7-methyl-(9CI)
|
154367-56-3
|
C8H7NO
|
|
3H-Pyrrolizin-3-one, 7-(hydroxymethyl)- (9CI)
|
154367-62-1
|
C8H7NO2
|
|
BETA-D-[1-13C]FRUCTOFURANOSYL ALPHA-D-GLUCOPYRANOSIDE
|
154368-11-3
|
C12H22O11
|
|
1-(3-CHLORO-4-FLUOROPHENYL)-2-THIOUREA
|
154371-25-2
|
C7H6ClFN2S
|
|
1-Benzyloxymethyl-2-butyl-4-iodoimidazole-5-carboxaldehyde
|
154371-51-4
|
C16H19IN2O2
|
|
N-Boc-4-piperidinepropionic acid
|
154375-43-6
|
C12H7F7O2
|
|
(2-Chloro-pyridin-3-yl)-cycloheptylidene-amine
|
154377-29-4
|
C12H15ClN2
|
|
1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethan-1-amine hydrochloride
|
154377-56-7
|
C12H17N
|
|
2-Ethyl-7-phenyl-1H-indene
|
154380-63-9
|
C17H16
|
|
1-O-decanoylpanal
|
154381-70-1
|
C25H36O6
|
|
1-O-dodecanoylpanal
|
154381-71-2
|
C27H40O6
|
|
2-Sulfanyl-5H,6H,7H-cyclopenta-[b]pyridine-3-carbonitrile
|
154384-01-7
|
C9H8N2S
|
|
2-THIOXO-1,2,5,6,7,8,9,10-OCTAHYDROCYCLOOCTA[B]PYRIDIN-3-YL CYANIDE
|
154384-02-8
|
C12H14N2S
|
|
2-METHYLSULFANYL-5,6,7,8-TETRAHYDRO-QUINOLINE-3-CARBONITRILE
|
154384-04-0
|
C11H12N2S
|
|
1H-Imidazole,1-ethyl-4-(1-methylethyl)-(9CI)
|
154385-47-4
|
C8H14N2
|
|
1H-Imidazole,1,4-bis(1-methylethyl)-(9CI)
|
154385-48-5
|
C9H16N2
|
|
1H-Imidazole,1-(1,1-dimethylethyl)-4-(1-methylethyl)-(9CI)
|
154385-49-6
|
C10H18N2
|
|
1H-Imidazole,4-(1,1-dimethylethyl)-1-(1-methylethyl)-(9CI)
|
154385-51-0
|
C10H18N2
|
|
2-Propanone, 1-[(1,1-dimethylethyl)amino]- (9CI)
|
154385-55-4
|
C7H15NO
|
|
6H-Pyrazolo[3,4-d]pyrimidin-6-one, 1,5-dihydro-3-methyl- (9CI)
|
154386-32-0
|
C6H6N4O
|
|
2-HYDROXY-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID
|
154386-35-3
|
C11H9NO4
|
|
Finasteride Carboxaldehyde
|
154387-61-8
|
C23H34N2O3
|
|
(5a,6a,17)-N-(1,1-Dimethylethyl)-6-hydroxy-3-oxo-4-azaandrost-1-ene-17-carboxamide
|
154387-62-9
|
C23H36N2O3
|
|
1H-Benzimidazole,1-(propoxymethyl)-(9CI)
|
154387-90-3
|
C11H14N2O
|
|
2(3H)-Furanone,5-ethoxydihydro-4-methyl-4-(trifluoromethyl)-,trans-(9CI)
|
154389-74-9
|
C8H11F3O3
|
|
2(3H)-Furanone,5-ethoxydihydro-4-methyl-4-(trifluoromethyl)-,cis-(9CI)
|
154389-75-0
|
C8H11F3O3
|
|
1H-Pyrazolo[4,3-c]pyridine,4,6-dimethyl-(9CI)
|
154390-78-0
|
C8H9N3
|
|
1H-Cyclopentapyrazine,octahydro-(9CI)
|
154393-81-4
|
C7H14N2
|
|
1H-Cyclopentapyrazine,octahydro-1,4-dimethyl-(9CI)
|
154393-82-5
|
C9H18N2
|
|
3-Pyridinemethanimine(9CI)
|
154394-30-6
|
C6H6N2
|
|
1,2,3,4,6-Penta-O-acetyl-b-D-glucopyranose
|
154395-36-5
|
C16H22O11
|
|
Fmoc-L-Asn(beta-D-Glc(Ac)4-OH
|
154395-64-9
|
C33H36N2O14
|
|
RK-397
|
154396-73-3
|
C35H56O10
|
|
casomokinin L
|
154396-74-4
|
C39H52N6O8
|
|
2-Cyclopenten-1-ol,4-amino-5-(methylthio)-,[1R-(1alpha,4alpha,5beta)]-(9CI)
|
154396-79-9
|
C6H11NOS
|
|
Napsagatran
|
154397-77-0
|
C26H34N6O6S
|
|
Iopromide EP Impurity E
|
154397-78-1
|
C32H37I6N5O14
|
|
2,4,6-tris(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine
|
154403-27-7
|
C18H21N9
|
|
3-Pyridineacetonitrile,6-methoxy-(9CI)
|
154403-85-7
|
C8H8N2O
|
|
RARECHEM AN KA 0869
|
154403-89-1
|
C8H12N2O
|
|
7(4H)-Benzothiazolone, 5,6-dihydro-2-(4-pyridinyl)-
|
154404-90-7
|
C12H10N2OS
|
|
N-(7-oxo-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)acetamide
|
154404-97-4
|
C9H10N2O2S
|
|
ETHYL 2-METHYL-5-OXO-4-PHENYL-5,6,7,8-TETRAHYDRO-3-QUINOLINECARBOXYLATE
|
154405-24-0
|
C19H19NO3
|
|
3-(2-bromophenoxy)propanenitrile
|
154405-38-6
|
C9H8BrNO
|
|
2-bromo-3'-chloro-1,1'-biphenyl
|
154407-17-7
|
C12H8BrCl
|
|
(Z)-Methyl 2-(hydroxyiMino)-2-(pyridin-2-yl)acetate
|
154410-82-9
|
C8H8N2O3
|
|
Methyl 2-amino-2-(pyridin-2-yl)acetate
|
154410-83-0
|
C8H10N2O2
|
|
N-(1-CYANO-4-OXO-4H-QUINOLIZIN-3-YL)BENZENECARBOXAMIDE
|
154411-16-2
|
C17H11N3O2
|
|
Bicyclo[6.1.0]non-4-ene, 9,9-difluoro- (9CI)
|
154413-30-6
|
C9H12F2
|
|
Cyclopropane, 1,1-difluoro-2-[(2-propenyloxy)methyl]- (9CI)
|
154413-34-0
|
C7H10F2O
|
|
Cyclopropane, 1,1-difluoro-2,3-dipropyl-, trans- (9CI)
|
154413-35-1
|
C9H16F2
|
|
Cyclopropane, 1,1-difluoro-2,3-dipropyl-, cis- (9CI)
|
154413-36-2
|
C9H16F2
|